Teva Drops 2 Copaxone Claims Against Sandoz
Teva Pharmaceuticals Industries Ltd. has dropped claims for unfair competition and trade secrets misappropriation against Sandoz Inc. and parent company Novartis AG in a patent dispute over the multiple sclerosis drug...To view the full article, register now.
Already a subscriber? Click here to view full article